Melt Pharmaceuticals
Melt Pharmaceuticals is a startup headquartered in Brentwood, United States, founded in 2019. It has raised at least $42.3m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Melt Pharmaceuticals has raised at least $42.3m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Melt Pharmaceuticals sits inside the Nashville R&D ecosystem in the Global R&D Labs Directory.
Other startups in Brentwood
Related
- Innovation profile of Brentwood
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Melt Pharmaceuticals do?
Melt Pharmaceuticals is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has Melt Pharmaceuticals raised?
At least $42.3m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Melt Pharmaceuticals based?
Melt Pharmaceuticals is headquartered in Brentwood, United States.
When was Melt Pharmaceuticals founded?
Melt Pharmaceuticals was founded in 2019.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.